Rivaroxaban 2.5 Mg Oral Tablet
0040139
Phase 3 small_molecule completed
Quick answer
Rivaroxaban 2.5 Mg Oral Tablet for Chronic Kidney Diseases is a Phase 3 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Chronic Kidney Diseases
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed